News
Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m1086 (Published 17 March 2020) Cite this as: BMJ 2020;368:m1086Read an update to this news story
Related articles
- Feature Published: 18 March 2020; BMJ 368 doi:10.1136/bmj.m1090
- News Published: 23 March 2020; BMJ 368 doi:10.1136/bmj.m1168
- News Published: 17 April 2020; BMJ 369 doi:10.1136/bmj.m1555
See more
- Covid-19: Vaccine hesitancy and access affect uptake of new boostersBMJ October 02, 2023, 383 p2271; DOI: https://doi.org/10.1136/bmj.p2271
- Clinicians raise concerns over pilot of blood test for multiple cancersBMJ October 02, 2023, 383 p2268; DOI: https://doi.org/10.1136/bmj.p2268
- Environmental sustainability in healthcare systems: role of frugal innovationBMJ October 02, 2023, 383 e076381; DOI: https://doi.org/10.1136/bmj-2023-076381
- Martha’s rule and patients’ rights to a second opinionBMJ October 02, 2023, 383 p2221; DOI: https://doi.org/10.1136/bmj.p2221
- How to make “single use” surgical items more sustainableBMJ October 02, 2023, 383 p1524; DOI: https://doi.org/10.1136/bmj.p1524
Cited by...
- Deleterious drugs in COVID-19: a rapid systematic review and meta-analysis
- Cyclooxygenase inhibitor use is associated with increased COVID-19 severity
- Practical recommendations for the prevention and management of COVID-19 in low-income and middle-income settings: adapting clinical experience from the field
- Exploration of interethnic variation in the ibuprofen metabolizing enzyme CYP2C9: a genetic-based cautionary guide for treatment of COVID-19 symptoms
- Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection
- DrugWAS: Leveraging drug-wide association studies to facilitate drug repurposing for COVID-19
- Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives
- Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years
- Rapid implementation of mobile technology for real-time epidemiology of COVID-19
- Adverse effects of non-steroidal anti-inflammatory drugs in patients with viral respiratory infections: rapid systematic review
- The hospitalized patient with COVID-19 on the medical ward: Cleveland Clinic approach to management
- Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019
- The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action
- Rapid implementation of mobile technology for real-time epidemiology of COVID-19
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
- Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide
- Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear
- Covid-19: European drugs agency to review safety of ibuprofen